Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1141 of 1,261
  1. US 6838076

    Pulmonary administration of chemically modified insulin

    Nektar Therapeutics Β· Granted Jan 4, 2005 Β· Expires Dec 30, 2024

    expired
  2. US 6838075

    Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation

    Nektar Therapeutics Β· Granted Jan 4, 2005 Β· Expires Dec 30, 2024

    expired
  3. US 6838574

    Dicarba-closo-dodecarborane derivatives

    Institute of Medicinal Molecular Design, Inc. Β· Granted Jan 4, 2005 Β· Expires Dec 30, 2024

    expired
  4. US 6838528

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation Β· Granted Jan 4, 2005 Β· Expires Dec 30, 2024

    expired
  5. US 6838073

    Cobalamin conjugates useful as imaging and therapeutic agents

    Regents of the University of Minnesota Β· Granted Jan 4, 2005 Β· Expires Dec 30, 2024

    expired
  6. US 6835744

    3,3-substituted indoline derivatives

    Ligand Pharmaceuticals Incorporated Β· Granted Dec 28, 2004 Β· Expires Dec 23, 2024

    expired
  7. US 6835818

    Mutants of Streptococcal toxin C and methods of use

    Regents of the University of Minnesota Β· Granted Dec 28, 2004 Β· Expires Dec 23, 2024

    expired
  8. US 6835372

    Compositions comprising an active agent

    Nektar Therapeutics Β· Granted Dec 28, 2004 Β· Expires Dec 23, 2024

    expired
  9. US 6835326

    Fluorescent ink compositions comprising functionalized fluorescent nanocrystals

    BioCrystal, Ltd. Β· Granted Dec 28, 2004 Β· Expires Dec 23, 2024

    expired
  10. US 6835564

    Human endothelin converting enzyme-like proteins and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Dec 28, 2004 Β· Expires Dec 23, 2024

    expired
  11. EP 1488787

    Topisch anzuwendende stabilisierte Arzneimittel enthaltend Ketoprofen

    BERLIN CHEMIE AG [DE] Β· Granted Dec 22, 2004 Β· Expires Dec 17, 2024

    expired
  12. US 6833349

    Methods of treating inflammatory skin diseases

    REGENERON PHARMACEUTICALS, INC. Β· Granted Dec 21, 2004 Β· Expires Dec 16, 2024

    expired
  13. US 6833381

    TNF-&agr; inhibitors

    Takeda Chemical Industries Ltd. Β· Granted Dec 21, 2004 Β· Expires Dec 16, 2024

    expired
  14. US 6833264

    Hyaluronan synthase gene and uses therof

    The Board of Regents of the University of Oklahoma Β· Granted Dec 21, 2004 Β· Expires Dec 16, 2024

    expired
  15. US 6833128

    Method for monitoring local reaction associated with injections

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 21, 2004 Β· Expires Dec 16, 2024

    expired
  16. US 6833132

    Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Dec 21, 2004 Β· Expires Dec 16, 2024

    expired
  17. US 6831105

    Compositions comprising ether compounds and pharmaceutical uses therefor

    Esperion Therapeutics, Inc. Β· Granted Dec 14, 2004 Β· Expires Dec 9, 2024

    expired
  18. US 6830749

    Recombinant P53 adenovirus methods and compositions

    The Board of Regents of the University of Texas System Β· Granted Dec 14, 2004 Β· Expires Dec 9, 2024

    expired
  19. US 6830893

    T20/DP178 is an activator of human phagocyte formyl peptide receptors

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 14, 2004 Β· Expires Dec 9, 2024

    expired
  20. US 6831150

    Reductive alkylation process

    Theravance, Inc. Β· Granted Dec 14, 2004 Β· Expires Dec 9, 2024

    expired
  21. US 6831093

    Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof

    The Regents of the University of California Β· Granted Dec 14, 2004 Β· Expires Dec 9, 2024

    expired
  22. US 6831070

    Delivery of therapeutic gene products by intestinal cell expression

    The Regents of the University of California Β· Granted Dec 14, 2004 Β· Expires Dec 9, 2024

    expired
  23. US 6828309

    Use of pentosan polysulfate to treat certain conditions of the prostate

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired
  24. US 6828351

    Methods and compositions for regulating memory consolidation

    Sention, Inc. Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.